| 1 |
34731724 | FGF10/FGF17 as prognostic and drug response markers in acute myeloid leukemia. | 2022 Jan |
1 |
| 2 |
34836489 | A classification based on tumor-stroma ratio and tumor budding for patients with muscle-invasive bladder cancer. | 2022 Mar |
1 |
| 3 |
35173838 | SPINK2 is a prognostic biomarker related to immune infiltration in acute myeloid leukemia. | 2022 |
1 |
| 4 |
35378513 | miRNA-29 aggravates myocardial infarction via inhibiting the PI3K/mTOR/HIF1α/VEGF pathway. | 2022 Apr 4 |
1 |
| 5 |
35482249 | High Expression of C8orf76 Is an Independent Predictive Factor of Poor Prognosis in Patients with Breast Cancer. | 2022 Jun |
1 |
| 6 |
35517422 | Comprehensive analysis of expression signature and immune microenvironment signature of biomarker Endothelin Receptor Type A in stomach adenocarcinoma. | 2022 |
1 |
| 7 |
33490271 | COL1A1 Is a Potential Prognostic Biomarker and Correlated with Immune Infiltration in Mesothelioma. | 2021 |
1 |
| 8 |
33535978 | Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma. | 2021 Feb 3 |
1 |
| 9 |
33712026 | An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients. | 2021 Mar 12 |
1 |
| 10 |
34349094 | N6-Methyladenosine Regulators Are Involved in the Progression of and Have Clinical Impact on Breast Cancer. | 2021 Aug 5 |
1 |
| 11 |
34402138 | Chemokine C-C motif ligand 21 synergized with programmed death-ligand 1 blockade restrains tumor growth. | 2021 Nov |
1 |
| 12 |
34746118 | NR2F1-AS1/miR-190a/PHLDB2 Induces the Epithelial-Mesenchymal Transformation Process in Gastric Cancer by Promoting Phosphorylation of AKT3. | 2021 |
1 |
| 13 |
34900672 | A Starvation-Based 9-mRNA Signature Correlates With Prognosis in Patients With Hepatocellular Carcinoma. | 2021 |
1 |
| 14 |
34944712 | miR-154 Influences HNSCC Development and Progression through Regulation of the Epithelial-to-Mesenchymal Transition Process and Could Be Used as a Potential Biomarker. | 2021 Dec 13 |
1 |
| 15 |
32388719 | Expression and prognostic significance of pyruvate dehydrogenase kinase 1 in bladder urothelial carcinoma. | 2020 Nov |
1 |
| 16 |
32953737 | Pyrroline-5-carboxylate reductase 1 (PYCR1) upregulation contributes to gastric cancer progression and indicates poor survival outcome. | 2020 Aug |
1 |
| 17 |
32994818 | Mammaglobin B may be a prognostic biomarker of uterine corpus endometrial cancer. | 2020 Nov |
1 |
| 18 |
33102202 | Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma. | 2020 |
1 |
| 19 |
33194434 | Increased expression of POLR3G predicts poor prognosis in transitional cell carcinoma. | 2020 |
1 |
| 20 |
33268783 | LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis. | 2020 Dec 2 |
2 |
| 21 |
33392085 | A Five-lncRNAs Signature-Derived Risk Score Based on TCGA and CGGA for Glioblastoma: Potential Prospects for Treatment Evaluation and Prognostic Prediction. | 2020 |
1 |
| 22 |
30911000 | Connectivity map identifies luteolin as a treatment option of ischemic stroke by inhibiting MMP9 and activation of the PI3K/Akt signaling pathway. | 2019 Mar 25 |
1 |
| 23 |
29428729 | Downregulated CDKN1C/p57kip2 drives tumorigenesis and associates with poor overall survival in breast cancer. | 2018 Feb 26 |
1 |
| 24 |
29453409 | A Potential Prognostic Long Noncoding RNA Signature to Predict Recurrence among ER-positive Breast Cancer Patients Treated with Tamoxifen. | 2018 Feb 16 |
1 |
| 25 |
29156689 | Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cells. | 2017 Oct 17 |
1 |
| 26 |
23899375 | Translating imaging results into tumor biology: FDG-PET and the response to chemoradiation in human cervical carcinoma. | 2013 Sep |
1 |
| 27 |
22235101 | Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer. | 2012 Mar 1 |
1 |